Laboratoire L. Lafon

Becton Dickinson France S.a.

Other

Becton Dickinson France

Centre Technique Industriel Dit: Institut Textile De France

Laboratoire Aguettant

Probiotec (sarl)

Philippe Laurent

Jean-Pierre Grimard

Franck Carrel

Frédéric Perot

Roger Chatelin

Louis Gavet

Vincent Guyot

Michel Sotton

Robert Guigal

Guillaume Bonnefond

This medical device () comprises a pre-filled syringe () comprising a syringe body () and a piston () mounted sliding in the syringe body (), the syringe body () and the piston () delimiting an internal chamber () containing a fluid to be administered; and a package () in which the pre-filled syringe () is arranged, the package () comprising first and second package portions () mounted movable relative to each other between a storage configuration in which the first and second package portions () prevent the pre-filled syringe () from being removed from the package (), and an open configuration in which the first and second package portions () allow the pre-filled syringe () to be removed from the package (), a movement of the first and second package portions () from the storage configuration to the open configuration causing the piston () to move from a first piston position to a second piston position.

Medical device including a package and a pre-filled syringe disposed in the package

The invention relates to an adaptor for coupling with a medical container closed by a septum, the adaptor comprising:&#x2014;a gripping member () for securing the adaptor to the medical container,&#x2014;a needle access port intended to face an outer surface of the septum,&#x2014;a pierceable elastomeric piece () having a longitudinal axis located into the needle access port, said pierceable elastomeric piece having a recess () with a proximal opening and an outer wall () in contact with the needle access port,&#x2014;attaching means for maintaining the elastomeric piece into the needle access port. The invention also relates to an assembly comprising such an adaptor and a medical container, and to the use of such an adaptor for preventing the contamination inside a medical container closed by a septum.

Adaptor for coupling with a medical container

Pharmaceutical dosage form for transdermal administration

Leaktight confinement appliance ( ), intended to cooperate with an independent receptacle ( ) containing a substance ( ), having its own means ( ) for transfer into and/or out of the receptacle, and with an independent means ( ) for delivery of a material. The appliance includes a handling chamber ( ) defined by a wall ( ) of flexible material substantially leaktight with respect to the external environment. A pouch is formed within the wall of the handling chamber ( ) for retaining an interconnection device. The handling chamber ( ) is arranged to connect at least the transfer means ( ) of the receptacle ( ) to the delivery means ( ) through the interconnection device.

Sealed confinement appliance, for delivering a substance

Sealed confinement device for connecting a container and means for delivering a substance

A composition is intended to form on the skin, by spraying from an erasol can, a film for the transdermal administration of an active agent, and the composition contains 0.01-10% by weight of lipophilic vitamins, hormones, nicotine, corticoids, retinoids, antimycosic agents, anistetics, anolgesics, or anti cancer agents for the skin, 0.5 to 25% by weight of an adhesive polysiloxane composition, 5 to 25% by weight of an absorption promoter, 25 to 95% by weight of a volatile solvent containing at least a volatile silicone, and 0.5 to 50% by weight of pressurized propellant gas, and the composition is substantially free from water.

Film forming composition for spraying on the skin

Use of (&agr;-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use

The invention relates to the use of a compound selected from:

Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for

Acetamide derivatives and their use as feeding behaviour modifiers

The invention relates to a process which comprises the crystallization of a calcium salt of chiral (R or S) lactic acid esterified with a racemic dihydropyridine.

Process for producing optically pure 1,4-dihydropyridines

Modafinil for the treatment of sleep apneas and ventilatory disorders of

The invention relates to a compound of formula: ##STR1## and its addition salts with pharmaceutically acceptable acids. These compounds are useful in therapy as sedatives. Figure none

1,2,5,6-tetrahydropyridine derivative, process for preparing it and its

The present invention relates to the use of modafinil for the manufacture of a medicinal product for the treatment of urinary and fecal incontinence and urethrovesical and anal sphincteral disorders.

Use of modafinil for the treatment of urinary and fecal incontinence

The device comprises at least one element for immobilizing certain molecules contained in the medium to be tested. According to the invention, the immobilizing element is in the form of a hydrophilic material fixed on the surface of a plane hydrophobic material, such as for example viscose fibers (2) implanted by flocking into a sheet (3) of polyvinyl chloride. The device (4) further comprises:

Growing community of inventors

Oullins, France

Philippe Laurent